Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.
A well-conducted retrospective cohort study with adequate sample size and multivariate adjustment showing safety advantages (fewer memory complaints, shorter recovery time) for bifrontal ECT in adolescents, though efficacy was equivalent and cognitive assessment was limited to subjective measures.
Uncontrolled retrospective case series with universal polypharmacy in a small sample (n=28) showing symptom improvement but unable to isolate lurasidone's independent contribution; authors explicitly acknowledge these limitations and call for prospective controlled studies.
A narrative review synthesizing clinical, biological, and digital evidence on diagnostic differentiation; proposes a multimodal framework but acknowledges no single marker is suitable for routine clinical use, reflecting guidance rather than definitive clinical trial evidence.
Single-centre observational study with modest sample size comparing research diagnoses to clinical records; identifies an underrecognition gap but lacks intervention, control group, or prospective validation of the diagnostic discrepancy.